The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

24 Apr 2020 07:00

RNS Number : 7210K
Catenae Innovation PLC
24 April 2020
 

24 April 2020

Catenae Innovation PLC

("Catenae", or the "Company")

 

Directorate Changes

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, is pleased to announce the appointment of Brian Thompson and John Farthing to the Board as Non-Executive Chairman and Chief Financial Officer, respectively, with immediate effect.

 

Kevin Everett, Interim Non-Executive Chairman since 17 July 2019 and Non-Executive Director since 16 May 2013, will step down from his role with immediate effect, to pursue other business interests.

 

Brian Thompson's proposed appointment was announced on 31 January 2020. Mr Thompson is an entrepreneur and is the founder owner of Newcastle-based B.T.I.C. Ltd, a successful business that has operated in the insurance industry since 1985. He is also a director of Third Eye Neurotech Ltd.

 

John Farthing's appointment as Chief Financial Officer of the Company was announced on 24 January 2019 and his proposed appointment to the Board was announced on 23 December 2019. John qualified as a Chartered Accountant in 1988. Following a career in stockbroking, John has experience working with both UK listed as well as private companies. John is also a Chartered Fellow of the Chartered Institute for Securities & Investment and a Liveryman of the Worshipful Company of World Traders.

 

Further disclosure on Brian Thompson and John Farthing pursuant to Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies is set out below.

 

In order to conserve the Company's working capital, the directors have agreed to take part of their remuneration in shares.

 

Guy Meyer, Interim Chief Executive Officer, commented: "I am delighted to welcome both Brian and John to the Catenae Board at this important time in our development. Their wealth of experience, expertise and business network will add considerable value as we take advantage of potential growth opportunities that are presenting themselves."

 

"I would also like to thank Kevin for his contribution to the Company and I wish him all the very best for the future."

 

"We look forward to updating the market on future progress in due course."

 

 

 

Pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, the following information is disclosed in respect of Brian William Thompson (aged 64) and John Farthing (aged 57):

 

In the 5 years preceding the date of this announcement, Brian Thompson held the following directorships and no partnerships:

 

Current directorships

Past directorships

B.T.I.C. Limited

B.T.I.C (Morpeth) Limited

Little Tinker Limited

Third Eye Technologies Limited

Listenear Limited

Lyncroft Finance Limited

Orbi-Tel Limited

Third Eye Neurotech Limited

 

Mr Thompson holds 31,318,797 ordinary shares in the Company, representing 29.2% of the Company's issued share capital and no options over ordinary shares in the Company.

 

In the 5 years preceding the date of this announcement, John Farthing held the following directorships and partnerships:

 

Current directorships / partnerships

Past directorships / partnerships

Cloisters Capital LLP

Beaufort Securities Limited*

Trust in Media Limited

Charchem Limited

Granville West Limited

Harper, Deane and Farthing Limited

Intoware Limited

Kingston Smith Pension Trustees LLP

Kiru Brand Limited

Niku Restaurant Company Limited

Niku Trading Limited**

Signitoff Limited

SXN21 Limited

 

*Beaufort Securities Limited, a company of which Mr Farthing was a director of until 2 March 2018, entered administration on 1 March 2018 and ended administration on 3 March 2020. There was only one insolvency case.

 

**Niku Trading Limited, a company of which Mr Farthing was a director of until 7 October 2016, entered liquidation within one month of Mr Farthing's tenure as director via a voluntary creditors liquidation. A liquidator was appointed on 18 October 2016 and the company was dissolved on 17 September 2019. There was only one insolvency case.

 

Crowd Source Solutions Limited, a company of which Mr Farthing was a director of, was dissolved via a members voluntary liquidation. A liquidator was appointed on 19 August 2013 and the company was dissolved on 28 October 2014 via a solvent liquidation.

 

Mr Farthing holds 1,341,702 ordinary shares in the Company, representing 1.25% of the Company's issued share capital and no options over ordinary shares in the Company.

 

 

There is no further information to be disclosed in relation to the appointments of Brian Thompson and John Farthing pursuant to AIM Rule 17 and Schedule 2 (g) of the AIM Rules for Companies.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Interim Chief Executive Officer of the Company.

 

 

- Ends -

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0) 191 580 8545

Guy Meyer, Interim Chief Executive Officer

Cairn Financial Advisers LLP (Nominated Adviser)

+44 (0)20 7213 0880

Liam Murray

Jo Turner

Brandon Hill Capital Limited Broker

Andy Gutmann

+44 (0) 20 3463 5000

+44 (0)78796 8313

 

Yellow Jersey PR (PR & IR)

+44 (0)20 3004 9512

Sarah Hollins

Annabel Atkins

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPPUCWCUPUGRW
Date   Source Headline
1st Jul 20203:12 pmRNSTotal Voting Rights
1st Jul 20202:06 pmRNSSecond Price Monitoring Extn
1st Jul 20202:00 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSCompletion of Cov-ID Project
30th Jun 20207:01 amRNSHalf-year Report
30th Jun 20207:00 amRNSFinal Results
26th Jun 20204:30 pmRNSExercise of Warrant
23rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20204:36 pmRNSPrice Monitoring Extension
19th Jun 20207:00 amRNSCov-ID Project Update
12th Jun 20209:58 amRNSIssue of Equity
11th Jun 20202:02 pmRNSShare Price Movement and Update
10th Jun 202012:30 pmRNSExercise of Warrant, Conversion & Issue of Equity
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
29th May 202012:24 pmRNSHolding(s) in Company
29th May 20207:00 amRNSAgreement with Newcastle Premier Health Ltd
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
21st May 20207:00 amRNSExercise of Warrant and Issue of Equity
18th May 20207:00 amRNSCov-ID Project Update
14th May 202012:49 pmRNSResult of General Meeting and Issue of Equity
1st May 20209:00 amRNSUpdate - Cov-ID Project
29th Apr 20205:09 pmRNSPosting of Circular and Notice of General Meeting
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSDirectorate Changes
23rd Apr 202012:19 pmRNSHolding(s) in Company
21st Apr 20202:05 pmRNSSecond Price Monitoring Extn
21st Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 20203:32 pmRNSConditional Placing to raise £320,000 and Update
17th Apr 20207:00 amRNSCatenae joins Consortium on Cov-ID Project
16th Apr 20205:30 pmRNSChange of Broker
31st Mar 20202:45 pmRNSHolding(s) in Company
31st Mar 20202:40 pmRNSHolding(s) in Company
31st Mar 20202:35 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNSAnnual Report, Trading & COVID-19 Update
26th Mar 202012:49 pmRNSWorking Capital Facility
31st Jan 20201:36 pmRNSIssue of Equity & Proposed Directorate Change
24th Jan 20201:20 pmRNSUpdate re Working Capital & Balance Sheet
10th Jan 202012:23 pmRNSUpdate re Working Capital & Balance Sheet
23rd Dec 201911:37 amRNSResult of General Meeting
20th Dec 20195:02 pmRNSUpdate re Working Capital
20th Dec 20191:23 pmRNSFurther re Share Capital & Timetable Update
20th Dec 20197:00 amRNSShare Capital and Total Voting Rights
19th Dec 20197:00 amRNSFurther re Agreements and update
6th Dec 201910:53 amRNSPosting of Circular and Notice of General Meeting
12th Sep 201910:50 amRNSHolding(s) in Company
11th Sep 20197:30 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.